TrialEuropean journal of pain (London, England)2026

The α2-Subunit Preferring GABA Positive Allosteric Modulator, N-Desmethyl-Clobazam in Peripheral Neuropathic Pain Patients: Results of a Phase IIa Randomised Placebo-Controlled Ascending Dose Study.

M Besson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.